drugset / Trial / NCT00936247

Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL)

NCT00936247

Phase 4 Terminated 2 enrolled B. Braun Melsungen AG
RandomizedParallel-groupSingle-blindTreatment

Summary

This investigational study will investigate two different volume replacement regimes in patients suffering from compromised renal function.

Timeline

Start
2009-11
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albumin Protein / enzyme biologic 5 %
Comparator NaCl Unknown 0.9 %
Subject Sterofundin ISO Other / unclassified
Subject Volulyte Other / unclassified 6 %